124 related articles for article (PubMed ID: 3978598)
1. Chromosome rearrangements in a metastatic adenocarcinoma of the prostate.
Gibas Z; Pontes JE; Sandberg AA
Cancer Genet Cytogenet; 1985 Apr; 16(4):301-4. PubMed ID: 3978598
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic evidence of intratumoral focal heterogeneity in prostatic carcinomas.
Wullich B; Breitkreuz T; Zwergel T; Unteregger G; Seitz G; Zang KD
Urol Int; 1992; 48(4):372-7. PubMed ID: 1413297
[TBL] [Abstract][Full Text] [Related]
3. Frequency and pattern of karyotypic abnormalities in human prostate cancer.
Brothman AR; Peehl DM; Patel AM; McNeal JE
Cancer Res; 1990 Jun; 50(12):3795-803. PubMed ID: 2340524
[TBL] [Abstract][Full Text] [Related]
4. Multiple structural chromosome rearrangements, including del(7q) and del(10q), in an adenocarcinoma of the prostate.
Lundgren R; Kristoffersson U; Heim S; Mandahl N; Mitelman F
Cancer Genet Cytogenet; 1988 Oct; 35(1):103-8. PubMed ID: 3180000
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic study of four cancers of the prostate.
Babu VR; Miles BJ; Cerny JC; Weiss L; Van Dyke DL
Cancer Genet Cytogenet; 1990 Aug; 48(1):83-7. PubMed ID: 2372791
[TBL] [Abstract][Full Text] [Related]
6. Karyotypic similarity identified by multiplex-FISH relates four prostate adenocarcinoma cell lines: PC-3, PPC-1, ALVA-31, and ALVA-41.
Varella-Garcia M; Boomer T; Miller GJ
Genes Chromosomes Cancer; 2001 Aug; 31(4):303-15. PubMed ID: 11433521
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic characterization of an established xenografted prostatic adenocarcinoma cell line (PC-82).
König JJ; Hagemeijer A; Smit B; Kamst E; Romijn JC; Schröder FH
Cancer Genet Cytogenet; 1988 Aug; 34(1):91-9. PubMed ID: 3395997
[TBL] [Abstract][Full Text] [Related]
8. Double minute chromosomes in an invasive adenocarcinoma of the prostate.
Milasin J; Mićić S
Cancer Genet Cytogenet; 1994 Feb; 72(2):157-9. PubMed ID: 8143277
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic studies of prostatic cancer.
Lundgren R
Scand J Urol Nephrol Suppl; 1991; 136():1-35. PubMed ID: 1871551
[TBL] [Abstract][Full Text] [Related]
10. Chromosome changes in benign prostatic hyperplasia and their significance in the origin of prostatic carcinoma.
Casalone R; Portentoso P; Granata P; Minelli E; Righi R; Meroni E; Pozzi E; Chiaravalli AM
Cancer Genet Cytogenet; 1993 Jul; 68(2):126-30. PubMed ID: 7689034
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal changes associated with progression of the Dunning R-3327 rat prostatic adenocarcinoma system.
Wake N; Isaacs J; Sandberg AA
Cancer Res; 1982 Oct; 42(10):4131-42. PubMed ID: 7105009
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours.
Alers JC; Krijtenburg PJ; Hop WC; Bolle WA; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
J Pathol; 1998 Jul; 185(3):273-83. PubMed ID: 9771481
[TBL] [Abstract][Full Text] [Related]
13. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
[TBL] [Abstract][Full Text] [Related]
14. Double minutes in two primary adenocarcinomas of the prostate.
Limon J; Lundgren R; Elfving P; Heim S; Kristoffersson U; Mandahl N; Mitelman F
Cancer Genet Cytogenet; 1989 Jun; 39(2):191-4. PubMed ID: 2752372
[TBL] [Abstract][Full Text] [Related]
15. Highly complex chromosomal aberrations in bone marrow of a patient with metastatic prostate neoplasm.
Azar GM; DiPillo F; Gogineni SK; Godec CJ; Verma RS
Cancer Genet Cytogenet; 1997 Dec; 99(2):116-20. PubMed ID: 9398865
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic support for primary prostatic cancer in a patient presenting with a soft tissue mass in the leg.
Molenaar WM; Stoepker ME; de Ruiter AJ; Hoekstra HJ; van den Berg E
Cancer Genet Cytogenet; 1996 Feb; 86(2):147-9. PubMed ID: 8603342
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal analysis of human prostatic adenocarcinoma cell lines.
Ohnuki Y; Marnell MM; Babcock MS; Lechner JF; Kaighn ME
Cancer Res; 1980 Mar; 40(3):524-34. PubMed ID: 7471073
[TBL] [Abstract][Full Text] [Related]
18. High frequency of clonal chromosome abnormalities in prostatic neoplasms sampled by prostatectomy or ultrasound-guided needle biopsy.
Teixeira MR; Waehre H; Lothe RA; Stenwig AE; Pandis N; Giercksky KE; Heim S
Genes Chromosomes Cancer; 2000 Jun; 28(2):211-9. PubMed ID: 10825006
[TBL] [Abstract][Full Text] [Related]
19. Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts.
Williams BJ; Jones E; Kozlowski JM; Vessella R; Brothman AR
Genes Chromosomes Cancer; 1997 Apr; 18(4):299-304. PubMed ID: 9087570
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization to assess transitional changes of aneuploidy for chromosomes 7, 8, 10, 12, 16, X and Y in metastatic prostate cancer following anti-androgen therapy.
Kasahara K; Taguchi T; Yamasaki I; Karashima T; Kamada M; Yuri K; Shuin T
Int J Oncol; 2001 Sep; 19(3):543-9. PubMed ID: 11494034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
